1270480

Fingolimodhydrochlorid

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): FTY720, 2-Amino-2-[2-(4-octyl-phenyl)-ethyl]-propan-1,3-diol -hydrochlorid, Fingolimod -hydrochlorid
• Empirische Formel (Hill-System): C₁₉H₃₃NO₂ · HCl
• CAS-Nummer: 162359-56-0
• Molekulargewicht: 343.93
• MDL number: MFCD00939512
• UNSPSC Code: 41116107
• NACRES: NA.24

Eigenschaften

• biological source: synthetic
• grade: pharmaceutical primary standard
• agency: USP
• API family: fingolimod
• form: powder
• manufacturer/tradename: USP
• storage condition: protect from light
• color: white
• solubility: DMSO: soluble, ethyl acetate: soluble, water: soluble
• application(s): pharmaceutical
• storage temp.: 2-8°C
• SMILES string: Cl.NC(CO)(CO)CCc1ccc(cc1)CCCCCCCC
• InChI: 1S/C19H33NO2.ClH/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22;/h9-12,21-22H,2-8,13-16,20H2,1H3;1H
• InChI key: SWZTYAVBMYWFGS-UHFFFAOYSA-N

Beschreibung

General description

Fingolimod Hydrochloride (fingolimod HCl), an S1P-receptor modulator, belongs to the class of synthetic glucocorticoid steroid drugs.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Fingolimod Hydrochloride USP reference standard may be used to quantify the analyte in gel, capsule and other pharmaceutical formulations, active pharmaceutical ingredient (API) and pharmaceutical dosage forms by liquid chromatography (LC) based techniques.

Biochem/physiol Actions

FTY720 ist ein immunmodulierendes Arzneimittel und Regulator des Sphingosin-1-phosphat (S1P)-Rezeptors. Die Phosphorylierung von FTY270 mittels Sphingosin-Kinase verursacht eine S1P1R-Internalisierung, die wiederum Lymphozyten in den Lymphknoten sequestriert und so daran hindert, an einer Autoimmunreaktion teilzunehmen. Es ist klinisch für die Behandlung von multipler Sklerose (MS) zugelassen. Außerdem blockiert und reversiert es nachweislich die von einer Paclitaxel-Chemotherapie induzierte peripherale Neuropathie (CIPN) mittels S1PR-Inhibition und hemmt die Aktivität von Histon-Deacetylasen im Hippocampus von Mausgehirnen, was die Gedächtnisleistung moduliert.

FTY720 ist ein immunmodulierendes Arzneimittel und wirkt als Regulator des Sphingosin-1-phosphat (S1P)-Rezeptors.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Sicherheitshinweise

• pictograms: GHS08
• signalword: Warning
• hcodes: H373
• pcodes: P260 - P314 - P501
• Hazard Classifications: STOT RE 2
• target_organs: Immune system
• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable